Systagenix Says 1,000 Clinicians Globally Trained In Its New Diagnostic Protease Activity Wound Test

Systagenix is trumpeting the fact that more than 1,000 clinicians from over 400 sites across Europe, the Middle East and South Africa have now been trained in the four months since the launch of WOUNDCHEK™ Protease Status, the world’s first point of care test for Elevated Protease Activity (EPA) in chronic wounds.

Most read

Latest

^